Table 3 Table showing data overlap between KEGG × Ingenuity
From: Consistency, comprehensiveness, and compatibility of pathway databases
KEGG × Ingenuity | ||||
|---|---|---|---|---|
Pathway Name | Gene Count | Pair Count | Gene % Overlap | Pair % Overlap |
Apoptosis Signaling | 89 vs 169 | 151 vs 3374 | 33(37%) | 21(14%) |
Axonal Guidance | 129 vs 213 | 308 vs 1843 | 85(66%) | 159(52%) |
Calcium Signaling | 179 vs 51 | 582 vs 202 | 18(35%) | 0(0%) |
Cell Cycle-G2M | 119 vs 13 | 78 vs 18 | 11(85%) | 11(61%) |
Cell cycle | 119 vs 31 | 78 vs 59 | 26(84%) | 6(10%) |
Fc epsilon RI signaling | 78 vs 75 | 184 vs 225 | 61(81%) | 108(59%) |
JAK/Stat Signaling | 155 vs 144 | 868 vs 3192 | 42(29%) | 88(10%) |
Actin Cytoskeleton Signaling | 217 vs 213 | 672 vs 2297 | 137(64%) | 230(34%) |
T cell receptor Signaling | 94 vs 63 | 175 vs 133 | 41(65%) | 39(29%) |
TGF-Beta Signaling | 87 vs 84 | 155 vs 113 | 12(14%) | 5(4%) |
VEGF Signaling | 74 vs 69 | 240 vs 167 | 29(42%) | 27(16%) |
Wnt Signaling | 152 vs 76 | 778 vs 134 | 33(43%) | 11(8%) |